Livagen 20 mg

INFORMATION:

- The product (substance) is not a food or dietary supplement, not suitable for human consumption.
- Keep out of the reach of children.
- Keep the container tightly closed.
- Store in a dry, cool, shaded place; protect from moisture.
- Store only in the original container.
- Avoid contact during pregnancy and lactation.
- Consult a doctor if you feel unwell or have adverse reactions from contact with the substance.

The scientific community is continually researching peptides to help fight numerous aging conditions. A key component of the research is to help reduce the symptoms of aging and the diseases associated with it. Numerous studies on older patients show that livagen interacts with many genes in lymphocytes that would otherwise stop responding with age. These results suggest that livagen has an immediate effect on DNA in lymphocytes, which are the main cells of the immune system. Livagen is a short bioregulatory peptide that has a direct effect on DNA structure and function. It is best known for its ability to decondensechromatin, thereby increasing the expression of certain genes and improving the "youthful" profile of cells. Its most studied action involves the lymphocytes of the immune system. Through these cells, Livagen has been shown to activate the immune system and compensate for diseases of the heart, gastrointestinal tract, immune system and central nervous system. Livagen research has also shown promise in the areas of nociception and pain control. Nociception refers to the physiological process of perceiving, feeling pain and responding to pain (pain reflex). Our tolerance to pain is increased.